CCL2 and chronic kidney disease: To date, serum and urinary MCP-1 concentrations resulted to significantly predict the incidence of microalbuminuria in patients with diabetes mellitus and normoalbuminuria (168); furthermore, urinary levels of the biomarker may be useful to predict disease progression and ESKD in patients with CKD (122).